A detailed history of Ckw Financial Group transactions in Incyte Corp stock. As of the latest transaction made, Ckw Financial Group holds 800 shares of INCY stock, worth $57,376. This represents 0.01% of its overall portfolio holdings.

Number of Shares
800
Previous 1,000 20.0%
Holding current value
$57,376
Previous $60,000 10.0%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $11,466 - $13,722
-200 Reduced 20.0%
800 $54,000
Q2 2022

Aug 04, 2022

BUY
$66.18 - $83.18 $13,236 - $16,636
200 Added 25.0%
1,000 $78,000
Q1 2022

Apr 28, 2022

BUY
$66.02 - $79.71 $13,204 - $15,941
200 Added 33.33%
800 $64,000
Q2 2021

Aug 05, 2021

BUY
$79.87 - $87.53 $35,941 - $39,388
450 Added 300.0%
600 $50,000
Q4 2020

Feb 10, 2021

SELL
$80.74 - $97.7 $4,036 - $4,885
-50 Reduced 25.0%
150 $13,000
Q4 2018

Jan 16, 2019

BUY
$58.5 - $69.94 $11,700 - $13,988
200 New
200 $13,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Ckw Financial Group Portfolio

Follow Ckw Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ckw Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Ckw Financial Group with notifications on news.